Post

Lilly collaborates with Aktis to strengthen radiopharma portfolio

Eli Lilly is once again expanding its scope in the radiopharmaceuticals space by entering into a multi-target discovery collaboration agreement …

Roche’s PI3K inhibitor secures breakthrough status in breast cancer

The US Food and Drug Administration (FDA) has granted Roche a breakthrough therapy designation for its breast cancer therapy inavolisib, …

Larimar resumes nomlabofusp programme after FDA lifts partial hold

Larimar Therapeutics’ clinical programme investigating nomlabofusp (CTI-1601) for the treatment of a neurodegenerative movement disorder is back on track after …

Pheon cashes in on ADC trend and raises $120m in Series B

UK-based Pheon Therapeutics has raised $120m in a Series B round to fund the clinical trials for its oncology pipeline …

Explainer: US Election 2024 -Biden’s healthcare outlook

As a presidential election looms in the US, the incumbent democratic party has made strides to win over public, party …